The findings will allow for more targeted treatment approaches.
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.
The Association of Independent Research Institutes named OMRF Vice President and Chief Financial Officer Tim Hassen as its new president.
The findings will help push clinicians closer to personalized medicine for lupus sufferers.
The new funding will support investigations into cellular mutations linked to rare skeletal diseases and vessel function.
Scientists have long known lupus has a strong genetic component, but there also must be environmental triggers to activate the disease.